Cd44 Epithelial Isoform Inversely Associates with Invasive Characteristics of Colorectal Cancer

References

• Arnold M , SierraMS, LaversanneM, SoerjomataramI, JemalA, BrayF. Global patterns and trends in colorectal cancer incidence and mortality. Gut66 (4), 683–691 (2017).
   PubMed Web of Science ®Google Scholar
• Jaggupilli A , ElkordE. Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity. Clin. Dev. Immunol.2012, 708036 (2012).
   PubMedGoogle Scholar
• Mirzaei A , MadjdZ, KadijaniAA, AlinaghiS, AkbariA, TavoosidanaG. Cancer stem cell's potential clinical implications. Int. J. Cancer Manag.10 (1), e5897 (2017).
   Google Scholar
• Mirzaei A , MadjdZ, KadijaniAAet al. Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methods. Cancer Biomark.17 (3), 301–311 (2016).
   PubMed Web of Science ®Google Scholar
• Mirzaei A , TavoosidanaG, RadAAet al. A new insight into cancer stem cell markers: could local and circulating cancer stem cell markers correlate in colorectal cancer? Tumour Biol. 37 (2), 2405–2414 (2016).
   PubMedGoogle Scholar
• Mirzaei A , TavoosidanaG, ModarressiMHet al. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients. Tumour Biol.36 (6), 4801–4810 (2015).
   PubMedGoogle Scholar
• Hatano Y , FukudaS, HisamatsuK, HirataA, HaraA, TomitaH. Multifaceted interpretation of colon cancer stem cells. Int. J. Mol. Sci.18 (7), 1446 (2017).
   PubMed Web of Science ®Google Scholar
• Yeung TM , GandhiSC, WildingJL, MuschelR, BodmerWF. Cancer stem cells from colorectal cancer-derived cell lines. Proc. Natl Acad. Sci. USA107 (8), 3722–3727 (2010).
   PubMed Web of Science ®Google Scholar
• Sneath R , ManghamD. The normal structure and function of CD44 and its role in neoplasia. Mol. Pathol.51 (4), 191 (1998).
   PubMedGoogle Scholar
• Kim H , YangX-L, RosadaC, HamiltonSR, AugustJT. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch. Biochem. Biophys.310 (2), 504–507 (1994).
   PubMed Web of Science ®Google Scholar
• Du L , WangH, HeLet al. CD44 is of functional importance for colorectal cancer stem cells. Clin. Cancer Res.14 (21), 6751–6760 (2008).
   PubMed Web of Science ®Google Scholar
• Pitule P , CedikovaM, DaumOet al. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients. Biomed. Res. Int.2014 (2014).
   Web of Science ®Google Scholar
• Ohara Y , OdaT, SuganoMet al. Histological and prognostic importance of CD 44+/CD 24+/E p CAM+ expression in clinical pancreatic cancer. Cancer Sci.104 (8), 1127–1134 (2013).
   PubMed Web of Science ®Google Scholar
• Ozawa M , IchikawaY, ZhengYet al. Prognostic significance of CD44 variant 2 upregulation in colorectal cancer. Br. J. Cancer111 (2), 365 (2014).
   PubMed Web of Science ®Google Scholar
• Fan C-W , WenL, QiangZ-Det al. Prognostic significance of relevant markers of cancer stem cells in colorectal cancer – a meta analysis. Hepatogastroenterology59 (117), 1421–1427 (2012).
   PubMedGoogle Scholar
• Horst D , KrieglL, EngelJ, KirchnerT, JungA. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer. Cancer Invest.27 (8), 844–850 (2009).
   PubMed Web of Science ®Google Scholar
• Detre S , JottiGS, DowsettM. A “quickscore” method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J. Clin. Pathol.48 (9), 876–878 (1995).
   PubMed Web of Science ®Google Scholar
• Rahman WFWA , Ab RahmanKS, NafiSNM, FauziMH, JaafarH. Overexpression of DNA methyltransferase 1 (DNMT1) protein in astrocytic tumour and its correlation with O6-methylguanine-DNA methyltransferase (MGMT) expression. Int. J. Clin. Exp. Pathol.8 (6), 6095 (2015).
   PubMed Web of Science ®Google Scholar
• Roudi R , KorourianA, ShariftabriziA, MadjdZ. Differential expression of cancer stem cell markers ALDH1 and CD133 in various lung cancer subtypes. Cancer Invest.33 (7), 294–302 (2015).
   PubMed Web of Science ®Google Scholar
• Mohsenzadegan M , MadjdZ, AsgariMet al. Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis. Cancer Immunol. Immunother.62 (10), 1609–1618 (2013).
   PubMed Web of Science ®Google Scholar
• Taeb J , AsgariM, AbolhasaniM, FarajollahiMM, MadjdZ. Expression of prostate stem cell antigen (PSCA) in prostate cancer: a tissue microarray study of Iranian patients. Pathol. Res. Pract.210 (1), 18–23 (2014).
   PubMed Web of Science ®Google Scholar
• Zanjani LS , MadjdZ, AbolhasaniMet al. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma. Exp. Mol. Pathol.103 (2), 218–228 (2017).
   PubMed Web of Science ®Google Scholar
• Wilson PM , LadnerRD, LenzH-J. Predictive and prognostic markers in colorectal cancer. Gastrointestinal Cancer Res.1 (6), 237 (2007).
   PubMedGoogle Scholar
• Ustaalioğlu BBÖ , TilkiM, KılıçoğluZGet al. Prognostic markers for metastatic colon cancer patients undergoing multiple metastasectomies. Turk. J. Gastroenterol.26, 386–391 (2015).
   PubMed Web of Science ®Google Scholar
• Choi Y-L , XuanYH, LeeS-Jet al. Enhanced CD24 expression in colorectal cancer correlates with prognostic factors. Korean J. Pathol.40 (2), 103–111 (2006).
   Google Scholar
• Weichert W , DenkertC, BurkhardtMet al. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin. Cancer Res.11 (18), 6574–6581 (2005).
   PubMed Web of Science ®Google Scholar
• Ahmed M , Al-AttarA, KimJet al. CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer. J. Clin. Pathol.62 (12), 1117–1122 (2009).
   PubMed Web of Science ®Google Scholar
• Bao B , AhmadA, AzmiAS, AliS, SarkarFH. Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy. Curr. Protoc. Pharmacol.61 (1), 14.25. 11–14.25. 14 (2013).
   Google Scholar
• Jing F , KimHJ, KimCH, KimYJ, LeeJH, KimHR. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases. Int. J. Oncol.46 (4), 1582–1588 (2015).
   PubMed Web of Science ®Google Scholar
• Orian-Rousseau V . CD44 acts as a signaling platform controlling tumor progression and metastasis. Front. Immunol.6, 154 (2015).
   PubMed Web of Science ®Google Scholar
• Yan Y , ZuoX, WeiD. Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target. Stem Cells Transl. Med.4 (9), 1033–1043 (2015).
   PubMed Web of Science ®Google Scholar
• Nour El Hoda SI , SharafWM, HelmyDO, ZakiMM, BadawiMA, SolimanAS. Detection of cancer stem cells in colorectal cancer: histopathological and immunohistochemical study. Open Access Maced. J. Med. Sci.4 (4), 543 (2016).
   PubMedGoogle Scholar
• Biddle A , GammonL, FazilB, MacKenzieIC. CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition. PLoS ONE8 (2), e57314 (2013).
   PubMed Web of Science ®Google Scholar
• Tanabe KK , EllisLM, SayaH. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet341 (8847), 725–726 (1993).
   PubMed Web of Science ®Google Scholar
• Vogel JD , EskiciogluC, WeiserMR, FeingoldDL, SteeleSR. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the treatment of colon cancer. Dis. Colon Rectum60 (10), 999–1017 (2017).
   PubMed Web of Science ®Google Scholar
• Schneider NI , LangnerC. Prognostic stratification of colorectal cancer patients: current perspectives. Cancer Manag. Res.6, 291–300 (2014).
   PubMed Web of Science ®Google Scholar
• Akagi Y , AdachiY, KinugasaT, OkaY, MizobeT, ShirouzuK. Lymph node evaluation and survival in colorectal cancer: review of population-based, prospective studies. Anticancer Res.33 (7), 2839–2847 (2013).
   PubMed Web of Science ®Google Scholar